Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NASDAQ: RVPH · Real-Time Price · USD
0.5385
+0.0185 (3.56%)
At close: Aug 22, 2025, 4:00 PM
0.5406
+0.0021 (0.39%)
Pre-market: Aug 25, 2025, 9:06 AM EDT
RVPH Market Cap
RVPH has a market cap or net worth of $36.62 million as of August 25, 2025. Its market cap has increased by 51.60% in one year.
Market Cap
36.62M
Enterprise Value
26.37M
1-Year Change
51.60%
Ranking
Category
Stock Price
$0.54
Market Cap Chart
Since October 18, 2018, RVPH's market cap has increased from $25.21M to $36.62M, an increase of 45.26%. That is a compound annual growth rate of 5.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 36.62M | -56.56% |
| Dec 31, 2024 | 84.31M | -41.36% |
| Dec 29, 2023 | 143.78M | 65.49% |
| Dec 30, 2022 | 86.88M | 115.01% |
| Dec 31, 2021 | 40.41M | -49.95% |
| Dec 31, 2020 | 80.73M | 195.66% |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 638.90B |
| Johnson & Johnson | 431.79B |
| AbbVie | 372.04B |
| UnitedHealth Group | 278.42B |
| Novo Nordisk | 253.97B |
| AstraZeneca | 251.25B |
| Novartis AG | 246.51B |
| Abbott Laboratories | 230.77B |